GERMANY's DHL Express,
the world's leading express services firm, has launched an enhanced
US-Mexico pharma and clinical research service through DHL Medical
The DHL Medical Express (WMX) that DHL
started in Mexico last year minimises difficulty within a complex supply
chain, the company press release said.
With this service, DHL Express can manage the export and regulatory
requirements for urgent shipments with specific temperature requirements
- from several major cities in Mexico to most US destinations in less
than 24 hours.
The company's market-leading network in Mexico has been enhanced via the
DHL WMX clinical trial platform, which includes a bilingual customer
The service includes dry ice supplies and temperature-controlled
packaging, online bookings and supply ordering facilities that connects
Said DHL Americas life sciences chief Brian Bralynski: "Given the
complexity Ministry of Health approvals in Mexico, having an integrated
system enables DHL to begin the export process ahead of time when
samples arrive at our facilities."
Mr Bralynski said this enabled DHL to extend collection times, allowing
time to schedule patient visits and still export the day of collection.
DHL launched its integrated Medical Express service from Colombia in
2014 and has since expanded the service to Argentina, Chile, Costa Rica,
Dominican Republic, Ecuador, Guatemala, Panama and Peru. Expansion
plans for this service in the near future include Brazil and additional
markets within Mexico.